IBDEI22L ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33041,1,3,0)
 ;;=3^Facial Myokymia
 ;;^UTILITY(U,$J,358.3,33041,1,4,0)
 ;;=4^G51.4
 ;;^UTILITY(U,$J,358.3,33041,2)
 ;;=^5003996
 ;;^UTILITY(U,$J,358.3,33042,0)
 ;;=M31.6^^128^1675^27
 ;;^UTILITY(U,$J,358.3,33042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33042,1,3,0)
 ;;=3^Giant Cell Arteritis NEC
 ;;^UTILITY(U,$J,358.3,33042,1,4,0)
 ;;=4^M31.6
 ;;^UTILITY(U,$J,358.3,33042,2)
 ;;=^5011748
 ;;^UTILITY(U,$J,358.3,33043,0)
 ;;=R51.^^128^1675^28
 ;;^UTILITY(U,$J,358.3,33043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33043,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,33043,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,33043,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,33044,0)
 ;;=H53.47^^128^1675^29
 ;;^UTILITY(U,$J,358.3,33044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33044,1,3,0)
 ;;=3^Heteronymous Bilateral Field Defects
 ;;^UTILITY(U,$J,358.3,33044,1,4,0)
 ;;=4^H53.47
 ;;^UTILITY(U,$J,358.3,33044,2)
 ;;=^268847
 ;;^UTILITY(U,$J,358.3,33045,0)
 ;;=H50.50^^128^1675^30
 ;;^UTILITY(U,$J,358.3,33045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33045,1,3,0)
 ;;=3^Heterophoria
 ;;^UTILITY(U,$J,358.3,33045,1,4,0)
 ;;=4^H50.50
 ;;^UTILITY(U,$J,358.3,33045,2)
 ;;=^5006240
 ;;^UTILITY(U,$J,358.3,33046,0)
 ;;=H50.40^^128^1675^31
 ;;^UTILITY(U,$J,358.3,33046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33046,1,3,0)
 ;;=3^Heterotropia
 ;;^UTILITY(U,$J,358.3,33046,1,4,0)
 ;;=4^H50.40
 ;;^UTILITY(U,$J,358.3,33046,2)
 ;;=^5006237
 ;;^UTILITY(U,$J,358.3,33047,0)
 ;;=H53.462^^128^1675^32
 ;;^UTILITY(U,$J,358.3,33047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33047,1,3,0)
 ;;=3^Homonymous Bilateral Field Defects,Left Side
 ;;^UTILITY(U,$J,358.3,33047,1,4,0)
 ;;=4^H53.462
 ;;^UTILITY(U,$J,358.3,33047,2)
 ;;=^5006342
 ;;^UTILITY(U,$J,358.3,33048,0)
 ;;=H53.461^^128^1675^33
 ;;^UTILITY(U,$J,358.3,33048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33048,1,3,0)
 ;;=3^Homonymous Bilateral Field Defects,Right Side
 ;;^UTILITY(U,$J,358.3,33048,1,4,0)
 ;;=4^H53.461
 ;;^UTILITY(U,$J,358.3,33048,2)
 ;;=^5006341
 ;;^UTILITY(U,$J,358.3,33049,0)
 ;;=H50.53^^128^1675^34
 ;;^UTILITY(U,$J,358.3,33049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33049,1,3,0)
 ;;=3^Hyperphoria
 ;;^UTILITY(U,$J,358.3,33049,1,4,0)
 ;;=4^H50.53
 ;;^UTILITY(U,$J,358.3,33049,2)
 ;;=^5006241
 ;;^UTILITY(U,$J,358.3,33050,0)
 ;;=G43.909^^128^1675^35
 ;;^UTILITY(U,$J,358.3,33050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33050,1,3,0)
 ;;=3^Migraine,Not Intractable w/o Status Migrainosus
 ;;^UTILITY(U,$J,358.3,33050,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,33050,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,33051,0)
 ;;=D86.82^^128^1675^36
 ;;^UTILITY(U,$J,358.3,33051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33051,1,3,0)
 ;;=3^Multiple Cranial Nerve Palsies in Sarcoidosis
 ;;^UTILITY(U,$J,358.3,33051,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,33051,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,33052,0)
 ;;=H55.00^^128^1675^41
 ;;^UTILITY(U,$J,358.3,33052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33052,1,3,0)
 ;;=3^Mystagmus,Unspec
 ;;^UTILITY(U,$J,358.3,33052,1,4,0)
 ;;=4^H55.00
 ;;^UTILITY(U,$J,358.3,33052,2)
 ;;=^5006370
 ;;^UTILITY(U,$J,358.3,33053,0)
 ;;=H52.523^^128^1675^43
 ;;^UTILITY(U,$J,358.3,33053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33053,1,3,0)
 ;;=3^Paresis of Accommodation,Bilateral
